Gadopentetate

This page contains recent news articles, when available, and an overview of Gadopentetate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Time Running Out for Gadolinium Lawsuit  -  May 29, 2008
It is important that if you think that you may have been harmed by Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); US Recall News (press release),

Dynamic MRI color mapping estimates femoral head perfusion ...  -  May 14, 2008
All patients underwent PEICM with a 1.5 Tesla MRI machine using coronal fast spoiled gradient echo imaging (SPGR) sequences with gadopentetate dimeglumine Ortho SuperSite,

Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media ...  -  Apr 8, 2008
MAGNEVIST(R) (gadopentetate dimeglumine) injection: As with other contrast media, the possibility of serious or life-threatening anaphylactic or Earthtimes,

Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media ...  -  Apr 8, 2008
Inc. to make Magnevist(R) (gadopentetate dimeglumine) injection and Ultravist(R) (iopromide) injection available to members of the Amerinet network. Biloxi Sun Herald,

Intrathecal Gadolinium: Its Time Has Come?  -  Jan 11, 2008
In their report, the authors reviewed 19 patients with clinical SIH in whom 0.5 mL of gadopentetate dimeglumine diluted with 4 mL of saline was instilled AJNR (subscription),

NSF NFD Gadolinium Lawyers offer Nationwide Assistance to Patients  -  Jan 16, 2008
Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); Press Media Wire (Press Release),

Bayer healthcare Pharmaceuticals, healthtrust Purchasing Group ...  -  Nov 8, 2007
LP (healthtrust), to make Magnevist(R) (gadopentetate dimeglumine) Injection available to members of the healthtrust network. With more than 50 percent PR Newswire (press release),

Boxed Warning Added for Gadolinium-Based Contrast Agents  -  Oct 1, 2007
When the cause was identified, the most commonly reported agent was gadodiamide, followed by gadopentetate dimeglumine and gadoversetamide; Medscape (subscription)

Nephrogenic Systemic Fibrosis Predicts Early Mortality in Hemodialysis  -  Sep 27, 2007
In the subgroup of 90 patients for whom electronic records were available, 54 had been exposed to gadopentetate dimeglumine contrast during imaging studies, Medscape (subscription)

Contrast Agent Linked to Fibrosing Disorder in Dialysis Patients  -  Oct 1, 2007
The agents are magnevist (gadopentetate dimeglumine) injection, MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, Omniscan (gadodiamide) injection, MedPage Today,

Premier Extends Agreement With Bayer HealthCare Pharmaceuticals  -  Jul 23, 2007
PharmaLive.com (press release),Under the agreement, Bayer HealthCare Pharmaceuticals will provide its Magnevist(R) (gadopentetate dimeglumine) Injection contrast media used for Magnetic

TODAY ON PHARMALIVE.COM  -  03 Jul 2007
PharmaLive.com (press release),Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide);

MRI for Profit Scheme May Turn Deadly  -  Jun 10, 2007
Lawyers and Settlements,The 5 agents approved for use in the US include: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;

Gadolinium linked to MRI kidney failure gets New Boxed Warning  -  Jun 7, 2007
Lawyers and Settlements,Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide);

Committee for Medicinal Products for Human Use Summary of Positive ...  -  25 May 2007
PharmaLive.com (press release),...in MRI diagnosis of the CNS and the liver as shown in trials comparing OptiMARK with another contrast agent containing gadopentetate dimeglumine.

FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI  -  25 May 2007
NewsBlaze,Five gadolinium-based contrast agents have been approved for use in the United States: Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide);

FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents  -  May 23, 2007
MedPage Today,Gadodiamide was the most commonly reported agent, when a specific agent was identified, followed by gadopentetate dimeglumine and gadoversetamide.

MRI Contrast Agents May Pose Risk for Patients With Kidney Disease  -  Jan 16, 2007
Journal of American Medical Association (subscription),However, he added, gadopentetate dimeglumine is also known to have a relatively strong bond with its chelate. The medical community is also getting the word

Berlex, Premier Sign New Agreement  -  Jan 4, 2007
Business New Jersey (subscription),Under the agreement, Berlex will provide Premier members access to Magnevist (gadopentetate dimeglumine) Injection, a type of contrast medium used for

Berlex, Premier Sign New Agreement for Magnetic Resonance Contrast ...  -  Jan 4, 2007
Drug Newswire (press release),Under the terms of the agreement, Berlex will provide Premier members access to Magnevist(R) (gadopentetate dimeglumine) Injection, the leading contrast

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.